BioSpace News Archive

Business

ProPhase Labs Announces Record Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2021.

March 30, 2022
·
21 min read
Business

Prof. Avi Schroeder Joins SciSparc’s Scientific Advisory Board to Support the Company’s Development of SCI-160 for Treating Pain

SciSparc Ltd., a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced the appointment of Professor Avi Schroeder as a member of the Company’s Scientific Advisory Board.

March 30, 2022
·
4 min read
Bio NC

Thermo Fisher Scientific’s PPD Clinical Research Business Earns TOPRA Award for Regulatory Affairs Excellence in Supporting Novavax’s COVID-19 Vaccine Approval

The clinical research business of Thermo Fisher Scientific has won a 2021 TOPRA Award for Regulatory Excellence, recognizing the important role of its regulatory affairs team in expediting vaccine approvals during the COVID-19 global pandemic.

March 30, 2022
·
2 min read
Drug Development

FDA Clears ReAlta Life Science’s Phase 2 STAR Trial of RLS-0071 in Neonates with Hypoxic-Ischemic Encephalopathy

ReAlta Life Sciences today announced U.S. Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for a Phase 2 clinical trial of RLS-0071 in neonates with hypoxic-ischemic encephalopathy (HIE).

March 30, 2022
·
3 min read
Deals

NAMSA to Acquire European-Based Medanex Clinic to Expand Early-Stage Preclinical Research Capabilities

NAMSA announced today its nearing acquisition of Medanex Clinic , a Belgium-based European preclinical research organization.

March 30, 2022
·
3 min read
Pharm Country

NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices

NanoVibronix, Inc. today announced the Company’s PainGuard and UroGuard, offered as private label products through Ideal Medical International Limited, have been approved by Health Canada.

March 30, 2022
·
4 min read
VoxNeuro Announces Significant Milestones as it Embarks on its Mission to Become “The Brain Company”

VoxNeuro Announces Significant Milestones as it Embarks on its Mission to Become “The Brain Company”.

March 30, 2022
·
4 min read
BioMidwest

Vertellus To Present Industry-Leading Portfolio of Medical Adhesives and Coatings at MD&M West 2022

Vertellus To Present Industry-Leading Portfolio of Medical Adhesives and Coatings at MD&M West 2022.

March 30, 2022
·
3 min read
Business

RenovoRx Reports Full Year 2021 Financial Results

RenovoRx, Inc today is reporting its financial results for the year ended December 31, 2021.

March 30, 2022
·
8 min read
On World Bipolar Day ALCEDIAG Announces EIT Health Supported EDIT-B Consortium Validating Innovative Blood Diagnostic Test for Bipolar Disorder

ALCEDIAG announces the launch of the EDIT-B Consortium, supported by the European Institute of Innovation and Technology for Health (EIT Health).

March 30, 2022
·
3 min read